226330 — Syntekabio Cashflow Statement

0.000.00%

Last trade - 00:00

TechnologyHighly SpeculativeSmall CapSucker Stock

Annual cashflow statement for Syntekabio, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-22,966	-6,488	-14,803	-4,506	-11,398
Depreciation
Amortisation
Non-Cash Items	18,643	12.5	6,821	-5,890	438
Unusual Items
Other Non-Cash Items
Changes in Working Capital	16,281	750	783	412	1,120
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	12,719	-4,668	-6,040	-8,511	-8,078
Capital Expenditures	-925	-886	-7,548	-8,757	-9,430
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-34,080	-10,500	-555	38,990	0
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-35,005	-11,386	-8,104	30,233	-9,430
Financing Cash Flow Items	373	261	197	0	—
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	39,122	1,488	25,209	-89	1,784
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	16,836	-14,567	11,058	21,634	-15,674